These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21952947)

  • 1. Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras.
    Acin S; Li Z; Mejia O; Roop DR; El-Naggar AK; Caulin C
    J Pathol; 2011 Dec; 225(4):479-89. PubMed ID: 21952947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 gain of function is interwoven into the hallmarks of cancer.
    Solomon H; Madar S; Rotter V
    J Pathol; 2011 Dec; 225(4):475-8. PubMed ID: 22025211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H).
    Li Z; Gonzalez CL; Wang B; Zhang Y; Mejia O; Katsonis P; Lichtarge O; Myers JN; El-Naggar AK; Caulin C
    J Pathol; 2016 Oct; 240(2):224-34. PubMed ID: 27447534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
    Ganly I; Soutar DS; Brown R; Kaye SB
    Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations in human head and neck cancer cell lines.
    Kiuru A; Servomaa K; Grénman R; Pulkkinen J; Rytömaa T
    Acta Otolaryngol Suppl; 1997; 529():237-40. PubMed ID: 9288320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genic alterations in oral and head and neck squamous cell carcinomas: analysis of international literature].
    Raybaud H; Odin G; Fafet A; Santini J; Monteil RA
    Pathol Biol (Paris); 2003 Apr; 51(3):176-84. PubMed ID: 12781800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
    Nylander K; Dabelsteen E; Hall PA
    J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck.
    Hoffmann TK; Trellakis S; Okulicz K; Schuler P; Greve J; Arnolds J; Bergmann C; Bas M; Lang S; Lehnerdt G; Brandau S; Mattheis S; Scheckenbach K; Finn OJ; Whiteside TL; Sonkoly E
    Anticancer Res; 2011 Oct; 31(10):3151-7. PubMed ID: 21965721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck.
    Yeudall WA; Jakus J; Ensley JF; Robbins KC
    Mol Carcinog; 1997 Feb; 18(2):89-96. PubMed ID: 9049184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions.
    Matsuda H; Konishi N; Hiasa Y; Hayashi I; Tsuzuki T; Tao M; Kitahori Y; Yoshioka N; Kirita T; Sugimura M
    J Oral Pathol Med; 1996 May; 25(5):232-8. PubMed ID: 8835820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck.
    Kiaris H; Spandidos DA; Jones AS; Vaughan ED; Field JK
    Br J Cancer; 1995 Jul; 72(1):123-8. PubMed ID: 7599040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck.
    Scholes AG; Liloglou T; Snijders PJ; Hart CA; Jones AS; Woolgar JA; Vaughan ED; Walboomers JM; Field JK
    Int J Cancer; 1997 May; 71(5):796-9. PubMed ID: 9180148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
    Sakata K
    J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck.
    Cardinali M; Kratochvil FJ; Ensley JF; Robbins KC; Yeudall WA
    Mol Carcinog; 1997 Feb; 18(2):78-88. PubMed ID: 9049183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent p53 mutations in head and neck cancer.
    Somers KD; Merrick MA; Lopez ME; Incognito LS; Schechter GL; Casey G
    Cancer Res; 1992 Nov; 52(21):5997-6000. PubMed ID: 1394225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.